Correlation Between Agios Pharm and Exelixis
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Exelixis, you can compare the effects of market volatilities on Agios Pharm and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Exelixis.
Diversification Opportunities for Agios Pharm and Exelixis
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Agios and Exelixis is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Agios Pharm i.e., Agios Pharm and Exelixis go up and down completely randomly.
Pair Corralation between Agios Pharm and Exelixis
Given the investment horizon of 90 days Agios Pharm is expected to generate 1.62 times more return on investment than Exelixis. However, Agios Pharm is 1.62 times more volatile than Exelixis. It trades about 0.08 of its potential returns per unit of risk. Exelixis is currently generating about 0.09 per unit of risk. If you would invest 2,606 in Agios Pharm on August 27, 2024 and sell it today you would earn a total of 2,962 from holding Agios Pharm or generate 113.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Agios Pharm vs. Exelixis
Performance |
Timeline |
Agios Pharm |
Exelixis |
Agios Pharm and Exelixis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agios Pharm and Exelixis
The main advantage of trading using opposite Agios Pharm and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |